Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company's issued and ...

Wall St. Analysts Eric Bleeker and Austin Smith are kicking the New Year off in style with 12 trends for AI investors to ...

Impinj updated sales guidance for Q4 last night. Impinj will be discussing its results at a financial conference today. 10 ...

Travere Therapeutics shares fall after the FDA extends its review timeline for Filspari's sNDA in FSGS, pushing the decision ...

Since 2020, many companies in this cohort have split their stocks. Nvidia, Alphabet, Apple, Amazon, and Tesla have all split ...

Strive acquires Semler Scientific, boosting Bitcoin holdings to 12,797.9 BTC, but shares fall 12% after the all-stock deal ...

AnaptysBio (NASDAQ:ANAB) outlined plans for a corporate separation and highlighted upcoming clinical and royalty-related ...

The artificial intelligence (AI) revolution has transformed companies in just about every major sector of the economy. In the ...

The industry leader with the clearest path to become the next trillion-dollar company is one of Wall Street's most prolific ...

While the company missed Wall Street's earnings estimates in the third quarter, Netflix still has a number of compelling long ...

Amcor plc (NYSE:AMCR) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, Baird analyst Ghansham ...

Why the Klépierre Narrative Is Shifting Even as Fair Value Stays Put The latest update on Klépierre keeps the model fair value estimate steady at about €35.16 per share, but the assumptions behind ...